Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.080
+0.040 (3.85%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.22 million as of July 2, 2026. Its market cap has increased by 163.24% in one year.
Market Cap
4.22M
Enterprise Value
-9.13M
1-Year Change
163.24%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.22M, a decrease of -95.34%. That is a compound annual growth rate of -42.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.22M | -10.91% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 4.73M |
| Evogene | 4.56M |
| 60 Degrees Pharmaceuticals | 4.55M |
| Creative Medical Technology Holdings | 4.47M |
| Alzamend Neuro | 4.41M |
| Ensysce Biosciences | 4.17M |
| GeoVax Labs | 4.13M |
| Matinas BioPharma Holdings | 4.06M |